Bangalore: Admitting that there has been a delay in Rs 6395 crore 'Namma Metro' mass transport project, the new managing director of Bangalore Metro Rail Corporation Limited (BMRCL) N Sivasailam said the project is nine months behind schedule.

Bangalore: Chikungunya cases continued to admitted at both KC General Hospital and Sriramapura Referral Hospital in Bangalore on Thursday with 33 fresh suspected cases reported in both hospitals. While statewide 21,805 suspected cases of chikungunya have been reported, Health Minister B Sriramulu said that he received reports of suspected cases of dengue in three districts.

Bangalore: Ministers for Information and BWSSB Katta Subramanyam Naidu and Medical Education Ramachandra Gowda on Wednesday assured members in the Upper House that the government would not privatise lakes in and around Bangalore City. During the debate on the issue, the Ministers also promised that they would take steps to take back those lakes which have already been handed over to private parties.

Bangalore, DHNS: Instances of chikungunya continued to spiral in Bangalore City with over 260 suspected cases of the disease being reported since June 14 at K C General Hospital and Sriramapura Referral Hospital. About 36 fresh cases were reported on Wednesday. Most patients affected by the vector-borne disease were from Sriramapura, Ramchandrapura, Prakashnagar, Nagappa Garden, RC Pura, Bhashyam Nagar, Yeshwantpur and Malleswaram.

What is the feeling in the Railways about the proposed ideas?

Having seen the Metro in Delhi and Kolkata, the urban rail network in Mumbai and Chennai, the Bangalorean had always wondered why the City's existing railway llines weren't put to better use. After all, Bangalore had about a dozen railway stations criss-crossing the City...

Biopharma major Biocon is planning to set up a dedicated greenfield facility to manufacture tablet formulations. The Bangalore-based company currently outsources this activity. Biocon is in the tablet formulation market in a small way now across the nephrology, diabetology, cardiology and oncology verticals. This segment accounts for about 10% of Biocons revenues, which it hopes to more than double to 25% in the next three to four years with its own manufacturing facility. Biocon manufactures its own injectable formulations across all bio-pharma verticals that it operates in.

keeping in mind Bangalore's growing water demand, the city's water supply and sewerage board is working on a plan to treat waste water and supply it. "The plan is under design and expected to be

In which we attempt to assess what average Indians living in big cities think about India's environment, and to gauge their levels of awareness, attitudes, perception and concerns Methodology